What the CDC says you can do now that you re vaccinated sfgate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfgate.com Daily Mail and Mail on Sunday newspapers.
Poverty in the United States
Womenâs Voices
Includes recent extensive qualitative data on women living in poverty
Provides a framework for understanding poverty
Buy this book
Immediate eBook download after purchase Hardcover $119.99
Institutional customers should get in touch with their account manager Softcover $119.99
Institutional customers should get in touch with their account manager
This important text explores the deep relationships between poverty, health/mental health conditions, and widespread social problems as they affect the lives of low-income women. A robust source of both empirical findings and first-person descriptions by poor women of their living conditions, it exposes cyclical patterns of structural and environmental stressors contributing to impaired physical and mental health. Psychological conditions (notably depression and PTSD), substance use and abuse, domestic and gu
States like Texas and Mississippi are lifting COVID-19 mask mandates, but with the pace of vaccinations and spread of variants, experts say it s too soon msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Science for just $15 USD.
Prolonged prevention of autoimmune diabetes
Teplizumab was previously shown in a clinical trial to delay onset of type 1 diabetes (T1D) in high-risk relatives of individuals with T1D. Now, Sims
et al. extend the follow-up analysis of this trial by 12 months, finding that efficacy of the initial 2-week treatment course persisted, with an extended time to T1D diagnosis in the teplizumab-treated group. Clinical benefits associated with reversed C-peptide decline improved beta cell function and partial exhaustion in CD8
+ T cells in the treated patients. HbA1c did not differ between placebo and treatment groups. This follow-up study further supports the use of anti-CD3 treatment for the prevention of T1D.